Allergy Therapeutics to present at the Cowen 42nd Annual Health Care Conference

Allergy Therapeutics plc (LON:AGY), the fully integrated specialty pharmaceutical company specialising in allergy vaccines, today announced that Manuel Llobet, Chief Executive Officer, Nick Wykeman, Chief Financial Officer, and Alan Bullimore, Head of Business Innovation of Allergy Therapeutics, will present at the Cowen 42nd Annual Health Care Conference taking place from 07-09 March 2022.

The presentation will review data supporting the upcoming clinical trials for the Group’s lead pipeline candidates including Grass MATA MPL, which is expected to enter Phase III development in Q3 2022, and VLP Peanut, which is on track to enter the clinic in the Phase I PROTECT trial later this year.   

A replay of the presentation will be made available under the ‘Investors’ section on Allergy Therapeutics’ website at www.allergytherapeutics.com/investors/results-reports-and-presentations/.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

More articles like this

Allergy Therapeutics Subscription to raise £7 million

Allergy Therapeutics plc (LON:AGY), the fully integrated specialty pharmaceutical company specialising in allergy immunotherapy, today announces a conditional Subscription by the Subscribers, Southern Fox and ZQ Capital (acting through its affiliate SkyGem), to raise £7 million at an

Online group supports parents coping with child allergies

A mother has set up a support group for parents coping with child allergies, offering them a “safe place to share”. Mother-of-two Claire Stone, from Thorndon, Suffolk, started Pippa Friendly to help other families in the same boat

Beware of ‘thunder fever

Doctors today warned asthmatics and hay fever sufferers face a higher risk of deadly allergic reactions due to the current thunderstorms. The combination of high pollen counts and wet weather creates a phenomenon known as ‘thunder fever’ or ‘thunderstorm

Allergies in children have risen seven-fold in past 15 years

Allergies in children have soared seven-fold in the last 15 years, new research shows. Now four in every ten children are allergic to something and scientists are still trying to understand what is causing the dramatic rise. Britain has

Are allergies hereditary?

Introducing your kid to new foods should be a fun experience, but there’s a hidden danger that can make taste-testing a disaster: anaphylaxis, or a severe allergic reaction. Many allergies are mild and only result in occasional sniffles,

Parents warn of allergen danger after takeaway death

The parents of a teenager who died from an allergic reaction to a takeaway meal have said they want to help save lives by telling their daughter’s story. Megan Lee, 15, suffered irreversible brain damage after being served

How long hayfever season lasts in the UK and when it peaks

More than 20 per cent of the population suffers from hayfever, making it the most common health condition in the UK. Hayfever is principally an allergic reaction to pollen, but can be triggered by other allergens such as dust mites, animal

Allergy Therapeutics to showcase allergy immunotherapy at EAACI 2022

Allergy Therapeutics plc (LON:AGY), the fully integrated specialty pharmaceutical company specialising in allergy immunotherapy, has announced that the Group will be sharing key scientific findings from across its research portfolio at the upcoming European Academy of Allergy and

Charity says 10 severe reactions can strike at any time

Allergies can strike unexpectedly in children, with severe reactions to certain foods often being life-threatening. Allergy UK says childhood food allergies are becoming increasingly common, with around one in 12 young children affected. It comes as Made In Chelsea star

No more posts to show